Addictions Therapeutics Market Scope And Analysis

Report Code : TIPRE00015265
Category : Pharmaceuticals

No. of Pages : 150

Buy Now

Addictions Therapeutics Market Analysis, Trends, and Scope 2023 to 2031

Buy Now

Addictions Therapeutics Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 7.43 Billion
Market Size by 2031	US$ 14.49 Million
Global CAGR (2023 - 2031)	7.3%
Historical Data	2021-2023
Forecast period	2023-2031
Segments Covered	By Treatment Type Opioid Addiction Treatment Alcohol Addiction treatment Nicotine Addiction treatment Other substance addiction treatment By Drug Type Nalaxone Naltrexone Bupropion Disulfiram Nicotine replacement products Methadone Varenicline By Treatment Center Inpatient treatment center Residential treatment Center Outpatient Treatment Center By Distribution Channel Hospital Pharmacies Medical stores
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Indivior PLC Pfizer Inc GlaxoSmithKline Plc Bausch Health Companies Cipla Inc Orexo AB Purdue Pharma L P Alvogen Camurus AB Hikma Pharmaceuticals Plc

Addictions Therapeutics Market News and Recent Developments

The addictions therapeutics market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for addictions therapeutics:

In January 2023, Hikma Pharmaceuticals PLC launched Naloxone Hydrochloride Injection, USP, 2mg/2mL, in prefilled syringe (PFS) form. This drug is used for emergency treatment of a known or suspected opioid overdose and is the third PFS product launched. The injection is currently available in the US. (Source: Hikma Pharmaceuticals PLC, 2023)
In January 2022, Pfizer partnered with Swedish start-up Alex Therapeutics to venture into the digital therapeutics space. Alex Therapeutics' AI-based platform integrates both cognitive behavioral therapy (CBT) and Acceptance and Commitment Therapy (ACT) with AI to personalize care. The initial focus of their partnership is to create digital therapeutics for nicotine addiction treatment and will begin their efforts in the German market. (Source: Pfizer, 2022)

Addictions Therapeutics Market Report Coverage and Deliverables

The “Addictions Therapeutics Market Size and Forecast (2022–2030)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles